Cargando…
Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis
BACKGROUND: Cumulative exposure to one or more anticholinergic medications (“anticholinergic burden”) is associated with an increased risk of adverse outcomes, particularly among older individuals. Mirabegron, an oral selective β3-adrenergic receptor agonist, has demonstrated efficacy in managing th...
Autores principales: | Lozano-Ortega, Greta, Walker, David R., Johnston, Karissa, Mickle, Alexis, Harrigan, Sean, Rogula, Basia, Kristy, Rita M., Hairston, John C., Schermer, Carol R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595992/ https://www.ncbi.nlm.nih.gov/pubmed/32960422 http://dx.doi.org/10.1007/s40266-020-00792-9 |
Ejemplares similares
-
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020) -
Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
por: Szabo, Shelagh M, et al.
Publicado: (2019) -
Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study
por: Burnett, Arthur L., et al.
Publicado: (2020) -
A Method for Reconstructing Individual Patient Data From Kaplan-Meier Survival Curves That Incorporate Marked Censoring Times
por: Rogula, Basia, et al.
Publicado: (2022) -
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet
por: Herschorn, Sender, et al.
Publicado: (2020)